However, its therapeutic potential in other cancer types, including GC and NSCLC, remains largely unexplored [11, 12].Despite the growing therapeutic relevance of Nectin-4–particularly, there remains a lack of clinically validated molecular imaging tools to noninvasively assess Nectin-4 expression. Here, NECTIN4 is linked to gastric cancer.